International Reaction
The Food and Drug Administration on Thursday authorized a new migraine drug from Amgen Inc. and Novartis AG that doctors contend can change patients’ lives by obscure a series of migraine days suffered by patients any month.
The drug, called Aimovig, was shown in 3 clinical trials to do improved than remedy in obscure a occurrence of migraines.
Migraines…
Article source: https://www.wsj.com/articles/fda-approves-migraine-medicine-1526609838
